Abstract Body

Background

Differentiated service delivery models (DSDM) for antiretroviral therapy (ART), including multi-month dispensing (MMD), have been scaled up to improve treatment outcomes and reduce the burden on HIV care programs. However, evidence on their contribution to sustained virological suppression (3rd 95) within Ugandan programmatic settings remains limited. We examined the contribution of DSDM and MMD models in sustaining and achieving virological suppression among people living with HIV (PLHIV) in Kampala, Uganda.

Methods

We conducted a retrospective review and analysis of routinely collected data from October 2023 to June 2025 among PLHIV aged ≥18 years receiving ART in six selected private and high-volume public HIV clinics implementing DSDM and MMD interventions in Kampala. Socio-demographic and clinical characteristics data were abstracted from medical records and supplemented with routine program reports. The primary outcome was virological non-suppression (VNS), defined as HIV RNA ≥200 copies/mL. We used multivariable logistic regression to identify factors associated with VNS. 

Results

Of 15,644 PLHIV receiving care, 12,461 (80%) were in public clinics. Mean age was 39 years (SD ±10.7), and the majority (69%) were female. Overall VNS was 7% (n=1,043). In age-adjusted analysis, VNS was less likely among PLHIV enrolled in DSDMs (adjusted odds ratios [aOR]=0.32, 95% CI: 0.27–0.38) and those receiving MMD refills (aOR=0.15, 95% CI: 0.13–0.17). Similarly, longer duration on ART (aOR=0.91, 95% CI: 0.89–0.92) and absence of tuberculosis symptoms (aOR=0.42, 95% CI: 0.30–0.58) were associated with lower odds of virological non-suppression. However, male sex (aOR = 1.56, 95% CI: 1.34–1.82), never married or single (aOR = 1.45, 95% CI: 1.10–1.93), divorced/separated (aOR = 1.53, 95% CI: 1.11–2.10), and unknown marital status (aOR = 1.63, 95% CI: 1.31–2.03) were significantly more likely to experience VNS.  

Conclusions

A relatively low prevalence of virological non-suppression among PLHIV reflects substantial progress in HIV care and treatment programs in Kampala. These findings emphasize the need to scale up DSDM and MMD models while addressing gender and social disparities to sustain gains toward the UNAIDS 95-95-95 targets.